Two Sigma Advisers’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Two Sigma Advisers’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-25,900	Closed	-$22.5K	–	2645
2023 Q2	$22.5K	Sell	25,900 -8,900	-26%	-$6.35K	﹤0.01%	2321
2023 Q1	$24.3K	Hold	34,800	–	–	﹤0.01%	2509
2022 Q4	$28.5K	Sell	34,800 -9,700	-22%	-$9.56K	﹤0.01%	2405
2022 Q3	$46K	Buy	44,500 +11,900	+37%	+$19K	﹤0.01%	2381
2022 Q2	$53K	Buy	32,600 +2,600	+9%	+$5.4K	﹤0.01%	2474
2022 Q1	$88K	Buy	30,000 +5,200	+21%	+$18.2K	﹤0.01%	2522
2021 Q4	$119K	Buy	+24,800	New	+$160K	﹤0.01%	2389
2021 Q2	–	Sell	-143,800	Closed	-$1.12M	–	2763
2021 Q1	$1.12M	Sell	143,800 -57,200	-28%	-$572K	﹤0.01%	1594
2020 Q4	$1.86M	Sell	201,000 -94,000	-32%	-$817K	0.01%	1304
2020 Q3	$2.04M	Buy	295,000 +163,700	+125%	+$993K	0.01%	1154
2020 Q2	$861K	Buy	+131,300	New	+$474K	﹤0.01%	1649

Two Sigma Advisers's SURF Position: Q3 2023 in Review

Two Sigma Advisers sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 25,900 shares — an estimated $22.5K sold.

Two Sigma Advisers first reported a position in SURF in Q2 2020 and held it in 11 quarters. The position peaked at $2.04M in Q3 2020. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.

Two Sigma Advisers reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Two Sigma Advisers sold 25,900 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $22.5K.
Two Sigma Advisers first reported a position in Surface Oncology, Inc. Common Stock in Q2 2020 and held it in 11 quarters.
Two Sigma Advisers's Surface Oncology, Inc. Common Stock position peaked at $2.04M in Q3 2020.
0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.

Based on Two Sigma Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.